NLRP3 and atherosclerosis: Human atherosclerotic lesions show increased expression of the major components of NLRP3 [43], and inhibition of the NLRP3 inflammasome reduces atherosclerosis in Apoe-−/− and ApoE2-Ki mice [44,45].